J&J consumer sales
This article was originally published in The Tan Sheet
Executive Summary
Fourth quarter sales for McNeil Consumer & Specialty Pharmaceuticals rose 6% to $423 mil. in the U.S. but declined 8% in international markets to $67 mil. For the year, McNeil's domestic revenues increased 6% to $1.54 bil. and international sales dropped 10%, resulting in worldwide sales of $1.8 bil. for 2002, up 3%. Johnson & Johnson highlights strong growth for McNeil Nutritionals' Splenda sweetener and Viactiv calcium chews during the year in a 1Jan. 21 financials release. J&J women's health products recorded 2% worldwide sales gain to $1.25 bil. for the year while skin care revenues advanced 13% to $1.57 bil. on continued strength of Neutrogena, Clean & Clear, Aveeno...